The Application of Goal Attainment Scaling in Cervical Dystonia - An Exploratory Observational Pilot Study
Due to its heterogeneous manifestation an individualized approach to reach therapeutic goals in cervical dystonia (CD) is advantageous.The aim of the current study was to adapt goal attainment scaling (GAS) to drive the management of CD.38 patients with CD, regularly treated with botulinum neurotoxi...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2024
|
| Sorozat: | MOVEMENT DISORDERS CLINICAL PRACTICE
11 No. 8 |
| Tárgyszavak: | |
| doi: | 10.1002/mdc3.14118 |
| mtmt: | 34934438 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/32741 |
| LEADER | 02017nab a2200289 i 4500 | ||
|---|---|---|---|
| 001 | publ32741 | ||
| 005 | 20240913093814.0 | ||
| 008 | 240607s2024 hu o 000 eng d | ||
| 022 | |a 2330-1619 | ||
| 024 | 7 | |a 10.1002/mdc3.14118 |2 doi | |
| 024 | 7 | |a 34934438 |2 mtmt | |
| 040 | |a SZTE Publicatio Repozitórium |b hun | ||
| 041 | |a eng | ||
| 100 | 1 | |a Szabó Máté | |
| 245 | 1 | 4 | |a The Application of Goal Attainment Scaling in Cervical Dystonia - An Exploratory Observational Pilot Study |h [elektronikus dokumentum] / |c Szabó Máté |
| 260 | |c 2024 | ||
| 300 | |a 1013-1017 | ||
| 490 | 0 | |a MOVEMENT DISORDERS CLINICAL PRACTICE |v 11 No. 8 | |
| 520 | 3 | |a Due to its heterogeneous manifestation an individualized approach to reach therapeutic goals in cervical dystonia (CD) is advantageous.The aim of the current study was to adapt goal attainment scaling (GAS) to drive the management of CD.38 patients with CD, regularly treated with botulinum neurotoxin (BoNT), were involved in the current exploratory observational pilot study. GAS, including domains of motor, pain, disability, and psychiatric features, was applied to set up individualized goals with the calculation of initial GAS T-scores. Following at least 4 BoNT injection cycles, patients were reassessed whether they reached the pre-set goals.The initial GAS T-scores (median: 36.9, range: 22.8-40) significantly improved (P < 0.001) to the end of the study (the median of final GAS T-scores: 50, range: 25.5-63.6).The applicability of GAS in CD patients was confirmed, but further large-scale studies are needed refining this innovative approach. | |
| 650 | 4 | |a Klinikai orvostan | |
| 700 | 0 | 1 | |a Gárdián Gabriella |e aut |
| 700 | 0 | 1 | |a Szpisjak László |e aut |
| 700 | 0 | 1 | |a Salamon András |e aut |
| 700 | 0 | 1 | |a Gábor Tamás |e aut |
| 700 | 0 | 1 | |a Klivényi Péter |e aut |
| 700 | 0 | 1 | |a Zádori Dénes |e aut |
| 856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/32741/1/MovementDisordClinPract-2024-Szabo-TheApplicationofGoalAttainmentScalinginCervicalDystoniaAn.pdf |z Dokumentum-elérés |